Welcome to our dedicated page for Cartesian Growth Iii news (Ticker: CGCTU), a resource for investors and traders seeking the latest updates and insights on Cartesian Growth Iii stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cartesian Growth Iii's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cartesian Growth Iii's position in the market.
Cartesian Growth Corporation III has announced the pricing of its upsized IPO of 24 million units at $10.00 per unit, raising a total of $240 million. Each unit comprises one Class A ordinary share and one-half of one redeemable warrant, with whole warrants allowing purchase of one Class A share at $11.50. Trading will commence on Nasdaq under "CGCTU" on May 2, 2025.
The company's shares and warrants will later trade separately under "CGCT" and "CGCTW". Cantor Fitzgerald & Co. is the sole book-runner, with a 45-day option to purchase up to 3.6 million additional units. The offering is expected to close around May 5, 2025.
FAQ
What is the current stock price of Cartesian Growth Iii (CGCTU)?
